Wearable sensors may help identify people with multiple sclerosis (MS) who are more likely to have worsening disability and ...

Kavita Nair, PhD, discusses integrating neurology and pharmacy services to improve MS care coordination and reduce treatment delays. The integration of neurology and pharmacy services represents a ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Among adults with relapsing MS who received ublituximab, the annualized relapse rate continued to drop with up to 5 years of ...

New research suggests that multiple sclerosis may begin influencing patients’ health far earlier than previously recognized. Multiple sclerosis (MS) is often recognized only after unmistakable ...

Severity of multiple sclerosis (MS) was linked with geographic latitude, an observational study showed. Among 46,000 MS patients living in temperate zones, more severe disease was seen in those who ...

A study has demonstrated for the first time that diagnosis of multiple sclerosis (MS) can be significantly improved by additionally measuring the thickness of retinal layers in the eye. Use of the ...

People with MS had a 6% increased risk of developing any type of cancer compared with controls. Risks for bladder, brain, and cervical cancer were higher for people with MS. Risks for prostate, breast ...

Multiple sclerosis (MS) is a chronic autoimmune neurological disease that can cause symptoms throughout the body, including vision problems, muscle weakness, balance problems, cognitive dysfunction, ...

An estimated 2.8 million people live with MS worldwide, with prevalence increasing globally. Women make up about 75 percent ...

CLEVELAND, Ohio — In less than a year, the Cleveland Clinic’s $1 billion Neurological Institute will bring specialists who ...